April 24, 2012 -- Imaging software developer Definiens will be holding its 3rd International Definiens Symposium at its headquarters in Munich on 14-16 June.
The program will feature the latest trends in quantitative digital pathology and tissue-based biomarker development with leading experts from Roche, AstraZeneca, Novartis, as well as biomedical image and data analysis during hands-on workshops, Definiens said.
Definiens enhances its analysis software, March 19, 2012
Definiens provides boost for biomarkers, October 12, 2011
Aycan, Definiens team up, December 7, 2010